https://scholars.lib.ntu.edu.tw/handle/123456789/630519
標題: | Effects of different concentrations of atropine on controlling myopia in myopic children | 作者: | YUNG-FENG SHIH Chen, Chien Hsiung Chou, Ai Chuan TZYY-CHANG HO Lin, Luke L.K. Hung, Por Tying |
公開日期: | 1-一月-1999 | 卷: | 15 | 期: | 1 | 來源出版物: | Journal of Ocular Pharmacology and Therapeutics | 摘要: | Although 1% atropine effectively slows myopia progression, it is associated with adverse effects, including photophobia, blurred near vision, and poor compliance. We investigated whether lower doses of atropine would control myopia progression. One hundred and eighty-six children, from 6 to 13 years of age, were treated each night with different concentrations of atropine eye drops or a control treatment for up to 2 years. The mean myopic progression in each of the groups was 0.04 ± 0.63 diopter per year (D/Y) in the 0.5% atropine group, 0.45 ± 0.55 D/Y in the 0.25% atropine group, and 0.47 ± 0.91 D/Y in the 0.1% atropine group. All atropine groups showed significantly less myopic progression than the control group (1.06 ± 0.61 D/Y) (p<0.01). Our study also showed that 61% of students in the 0.5% atropine group, 49% in the 0.25% atropine group and 42% in the 0.1% atropine group had no myopic progression. However, 4% of children in the 0.5% atropine group, 17% in the 0.25% atropine group, and 33% in the 0.1% atropine group still had fast myopic progression (>-1.0 D/Y). In contrast, only 8% of the control group showed no myopic progression and 44% had fast myopic progression. These results suggest that all three concentrations of atropine had significant effects on controlling myopia; however, treatment with 0.5% atropine was the most effective. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/630519 | ISSN: | 10807683 | DOI: | 10.1089/jop.1999.15.85 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。